MedPath
Found 1 clinical trials|View Analysis
Sort by:

Post Transplant Cyclophosphamide (PTCY) as Sole Graft Versus Host Disease (GVHD) Prophylaxis for Matched Allotransplant: CYRIC

Phase 2
Terminated
Conditions
Graft Versus Host Disease
Interventions
Drug: Fludarabine
Drug: Clofarabine
Radiation: Full body irradiation
Drug: Cyclophosphamide
Other: stem cell transplantation
Other: nuclear cells
Drug: Thymoglobulin Injectable Product
First Posted Date
2017-08-28
Last Posted Date
2022-07-15
Lead Sponsor
Nantes University Hospital
Target Recruit Count
47
Registration Number
NCT03263767
Locations
🇫🇷

Nantes Uh, Nantes, France

© Copyright 2025. All Rights Reserved by MedPath